A detailed history of Raleigh Capital Management Inc. transactions in Haleon PLC stock. As of the latest transaction made, Raleigh Capital Management Inc. holds 60 shares of HLN stock, worth $509. This represents 0.0% of its overall portfolio holdings.

Number of Shares
60
Previous 169 64.5%
Holding current value
$509
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$8.02 - $8.67 $874 - $945
-109 Reduced 64.5%
60 $0
Q3 2023

Dec 06, 2023

BUY
$7.85 - $8.94 $855 - $974
109 Added 181.67%
169 $1,000
Q2 2023

Jul 25, 2023

BUY
$8.04 - $9.0 $482 - $540
60 New
60 $0
Q3 2022

Nov 09, 2022

BUY
$5.63 - $7.49 $45 - $59
8 New
8 $0

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $39.2B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Raleigh Capital Management Inc. Portfolio

Follow Raleigh Capital Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raleigh Capital Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raleigh Capital Management Inc. with notifications on news.